x

Search for a clinical trial

* (*) mandatory field

65 Result(s)

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

FRANCE

BOURGOGNE-FRANCHE-COMTE
DIJON

GERMANY

Bayern
MÜNCHEN

GERMANY

Nordrhein-Westfalen
ESSEN

ITALY

LOMBARDIA
MILANO

Activity and Safety of Second Line SOrafenib After Pazopanib in Patients With Metastatic Renal Cell Carcinoma (SOAP Study)
Fondazione IRCCS Istituto Nazionale dei Tumori
S.S. Oncologia medica genitourinaria

ITALY

LOMBARDIA
MILANO

Sorafenib in Recurrent and/or Metastatic Salivary Gland Carcinomas: Phase II Study
Fondazione IRCCS Istituto Nazionale dei Tumori
S.C. Oncologia Medica 3 - Tumori testa-collo

NETHERLANDS

Zuid-Holland
LEIDEN

UNITED KINGDOM

Avon
BRISTOL

A Phase III randomised, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinoma - UK
Bristol Royal Infirmary
University Hospitals Bristol NHS Foundation Trust HQ

UNITED KINGDOM

Oxfordshire
OXFORD

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

A Phase III randomised, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinoma - UK
Freeman Hospital, The newcastle upon Tyne Hospitals NHS Foundation Trust
The Newcastle upon Tyne Hospitals NHS Foundation Trust

Multinational clinical trial(s)